| Literature DB >> 29104227 |
Biruhalem Taye1,2,3, Dawn Yeo4, Raphael Tze Chuen Lee5, Boon Huan Tan6,7, Richard J Sugrue8, Sebastian Maurer-Stroh9,10.
Abstract
Low pathogenic avian influenza (LPAI) viruses are a source of sporadic human infections and could also contribute to future pandemic outbreaks but little is known about inter-species differences in the host responses to these viruses. Here, we studied host gene expression signatures of cell lines from three species (human, chicken, and canine) in response to six different viruses (H1N1/WSN, H5N2/F59, H5N2/F118, H5N2/F189, H5N3 and H9N2). Comprehensive microarray probe set re-annotation and ortholog mapping of the host genes was necessary to allow comparison over extended functionally annotated gene sets and orthologous pathways. The annotations are made available to the community for commonly used microarray chips. We observe a strong tendency of the response being cell type- rather than virus-specific. In chicken cells, we found up-regulation of host factors inducing virus infectivity (e.g., oxysterol binding protein like 1A (OSBPL1A) and Rho GTPase activating protein 21 (ARHGAP21)) while reducing apoptosis (e.g., mitochondrial ribosomal protein S27 (MRPS27)) and increasing cell proliferation (e.g., COP9 signalosome subunit 2 (COPS2)). On the other hand, increased antiviral, pro-apoptotic and inflammatory signatures have been identified in human cells while cell cycle and metabolic pathways were down-regulated. This signature describes how low pathogenic avian influenza (LPAI) viruses are being tolerated and shed from chicken but potentially causing cellular disruption in mammalian cells.Entities:
Keywords: apoptosis; influenza A virus; inter-species transcriptome; metabolic pathways
Mesh:
Year: 2017 PMID: 29104227 PMCID: PMC5713265 DOI: 10.3390/ijms18112295
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Overview of Affymetrix probe annotation and orthologs mapping. IDs = identifications, OMA = “Orthologous Matrix” database.
Annotation of affymetrix probe sets with no ensembl identifications (IDs).
| Probe Annotation | Chicken Genome Array | Canine Genome 2.0 Array |
|---|---|---|
| Total number of affymetrix probes | 38,535 | 43,035 |
| Total number of genes (ensembl IDs) | 12,639 | 16,602 |
| Probes without ensembl ID annotation | 16,055 | 13,195 |
| Probes annotated in this study (new) | 15,979 | 13,162 |
| Genes corresponding to the new annotation | 7412 | 6869 |
| New annotated genes represented by other affymetrix probes | 6229 | 5899 |
| New annotated genes unique to this study | 1183 | 970 |
| Total number of fully annotated probes | 38,474 | 43,006 |
| Total number of fully annotated genes | 14,007 | 17,813 |
The total number of genes (from ensembl genes 83) for Chicken and Canine are 17,108 and 24,580 respectively.
Human ortholog mapping of Canis familiaris (Canine) and Gallus gallus (Chicken) genes/probes.
| Ortholog Mapping | Gene/Probe | Chicken Orthologs | Canine Orthologs |
|---|---|---|---|
| Affymetrix orthologs | Probes | 14,415 (37.04) | 15,053 (34.97) |
| Genes | 8654 (61.78) | 9109 (51.13) | |
| Orthologous Matrix (OMA) orthologs | Genes | 11,674 (83.34) | 16,002 (89.83) |
| OMA orthologs common to the full annotation (ensemble ID) | Genes | 11,220 (80) | 15,284 (85.8) |
| Mapping OMA orthologs to Affymetrix probes | Genes | 11,175 (79.78) | 15,552 (87.30) |
| Probes | 32,244 (83.67) | 38,755 (90.05) | |
| Total Orthologs (OMA + Affymetrix) | Genes | 11,788 (84.15) | 15,577 (87.44) |
| Probes | 34,335 (89.10) | 39,436 (91.63) |
Comparison of orthologous differentially expressed genes (DEGs) in influenza A virus (IAV) infected A549 and Madin-Darby canine kidney (MDCK) cells.
| Virus Isolates | Post Infection | A549 | MDCK | Common | |
|---|---|---|---|---|---|
| All DEGs | |||||
| In all isolates | over all time points | 5684 | 13,737 | 5301 | <0.001 |
| H1N1/WSN | 6 h | 2 | 135 | 0 | 1 * |
| 10 h | 4173 | 10,683 | 3619 | <0.001 | |
| H9N2 | 6 h | 0 | 2 | 0 | - |
| 8 h | 19 | 1 | 0 | 1 * | |
| 10 h | 70 | 11 | 2 | 0.001 * | |
| H5N2/F118 | 4 h | 1 | 0 | 0 | - |
| 6 h | 33 | 0 | 0 | - | |
| 8 h | 83 | 17 | 1 | 0.087 * | |
| 10 h | 93 | 6106 | 40 | 0.45 | |
| H5N2/F59 | 10 h | 2269 | 2664 | 729 | <0.001 |
| H5N2/F189 | 10 h | 974 | 2194 | 281 | <0.001 |
| H5N3 | 10 h | 281 | 9691 | 192 | 0.033 |
| Up-regulated genes | |||||
| In all isolates | 1282 | 9765 | 871 | <0.001 | |
| H1N1/WSN | 6 h | 2 | 93 | 0 | 1 * |
| 10 h | 145 | 79 | 11 | <0.001 | |
| H9N2 | 6 h | 0 | 2 | 0 | - |
| 8 h | 18 | 1 | 0 | 1 * | |
| 10h | 61 | 8 | 2 | <0.001 | |
| H5N2/F118 | 4 h | 1 | 0 | 0 | - |
| 6 h | 30 | 0 | 0 | - | |
| 8 h | 54 | 3 | 1 | 0.01 | |
| 10 h | 40 | 131 | 2 | 0.044 * | |
| H5N2/F59 | 10 h | 957 | 83 | 35 | <0.001 |
| H5N2/F189 | 10 h | 459 | 31 | 6 | <0.001 |
| H5N3 | 10 h | 189 | 9664 | 136 | <0.001 |
| Down-regulated genes | |||||
| In all isolates | 4675 | 11,762 | 4220 | <0.001 | |
| H1N1/WSN | 6 h | 0 | 42 | 0 | - |
| 10 h | 4028 | 10,604 | 3532 | <0.001 | |
| H9N2 | 6 h | 0 | 0 | 0 | - |
| 8 h | 2 | 0 | 0 | ||
| 10 h | 9 | 3 | 0 | 1 * | |
| H5N2/F118 | 4 h | 0 | 0 | 0 | - |
| 6 h | 3 | 0 | 0 | - | |
| 8 h | 29 | 14 | 0 | 1 * | |
| 10 h | 53 | 5975 | 28 | 0.03 | |
| H5N2/F59 | 10 h | 1312 | 2581 | 587 | <0.001 |
| H5N2/F189 | 10 h | 515 | 2163 | 213 | <0.001 |
| H5N3 | 10 h | 92 | 27 | 5 | <0.001 |
* Fisher’s exact test, - not available.
Comparison of ortholog DEGs in IAV infected A549 and Chick embryo fibroblasts (CEF) cells.
| Virus Isolates | Post Infection | A549 | CEF | Common | |
|---|---|---|---|---|---|
| All DEGs | |||||
| In all isolates | over all time points | 4743 | 3716 | 2099 | <0.001 |
| H1N1/WSN | 4 h | 0 | 1 | 0 | |
| 6 h | 1 | 14 | 0 | 1 * | |
| 10 h | 3541 | 45 | 13 | 0.866 | |
| H9N2 | 8 h | 11 | 0 | 0 | |
| 10 h | 42 | 0 | 0 | ||
| H5N2/F118 | 6 h | 18 | 0 | 0 | |
| 8 h | 51 | 3645 | 18 | 0.498 | |
| 10 h | 65 | 84 | 0 | 1 * | |
| H5N2/F59 | 10 h | 1894 | 19 | 7 | 0.014 |
| H5N2/F189 | 10 h | 786 | 5 | 1 | 0.292 * |
| H5N3 | 10 h | 219 | 18 | 1 | 0.287 * |
| Up-regulated | |||||
| In all isolates | 980 | 159 | 32 | <0.001 | |
| H1N1/WSN | 6 h | 1 | 8 | 0 | |
| 10 h | 91 | 42 | 7 | <0.001 | |
| H9N2 | 8 h | 12 | 0 | 0 | |
| 10 h | 31 | 0 | 0 | ||
| H5N2/F118 | 6 h | 18 | 0 | 0 | |
| 8 h | 27 | 103 | 2 | 0.023 * | |
| 10 h | 24 | 11 | 0 | 1 * | |
| H5N2/F59 | 10 h | 756 | 13 | 5 | 0.001 * |
| H5N2/F189 | 10 h | 328 | 5 | 1 | 0.132 * |
| H5N3 | 10 h | 136 | 18 | 1 | 0.189 * |
| Down-regulated | |||||
| In all isolates | 3983 | 3573 | 1870 | <0.001 | |
| H1N1/WSN | 4 h | 0 | 1 | 0 | |
| 6 h | 0 | 6 | 0 | ||
| 10 h | 3450 | 3 | 1 | 1 * | |
| H9N2 | 8 h | 1 | 0 | 0 | |
| 10 h | 11 | 0 | 0 | ||
| H5N2/F118 | 6 h | 0 | 0 | 0 | |
| 8 h | 24 | 3542 | 9 | 0.425 | |
| 10 h | 41 | 73 | 0 | 1 * | |
| H5N2/F59 | 10 h | 1138 | 6 | 2 | 0.107 * |
| H5N2/F189 | 10 h | 458 | 0 | 0 | |
| H5N3 | 10 h | 83 | 0 | 0 | |
* Fisher’s exact test, - not available.
Figure 2Functional annotation of the DEGs in A549, CEF and MDCK cell lines during influenza A virus (IAV) infections at 10 hpi. (A) Functional annotation of both up-and down-regulated genes together; (B) functional annotation of up-regulated genes; (C) functional annotation of down-regulated genes. The suffix labelling A, C and M indicates the cell type A549, CEF and MDCK respectively, (e.g., A_10h H1N1/WSN, A549 cells infection with H1N1/WSN virus at 10 hpi).
Figure 3Correlation and clustering of the DEGs. (A) Correlation matrix of the DEGs in the three cell lines across the IAV infections at 10 hpi; (B) principal component analysis of the DEGs to identify the determinat genes in each cluster (species).
Figure 4Hierarchical clustering of the top 56 DEGs across the cell lines and virus infections. (A) hierarchical clustering of the top 56 DEGs at 10 hpi; (B) hierarchical clustering of the top 56 DEGs during temporal infections in three viruses (H1N1/WSN, H5N2/F118 and H9N2).
Figure 5DEGs and pathways involved in metabolic pathways. (A) Hierarchical clustering and heat map of the DEGs involved in metabolic pathways; (B) top 20 up-regulated metabolic pathways; (C) top 20 down-regulated metabolic pathways.